| scholarly article | Q13442814 |
| P50 | author | Emily E Rosowski | Q83104125 |
| Lindsay Julien | Q116996902 | ||
| Mariane B Melo | Q37383772 | ||
| Daniel Ajzenberg | Q45878773 | ||
| Lucy H. Young | Q54259866 | ||
| Musa A Hassan | Q57208597 | ||
| Vincent Butty | Q57208600 | ||
| Jeroen P Saeij | Q67222671 | ||
| P2093 | author name string | Marie-Laure Dardé | |
| Ninghan Yang | |||
| Quynh P Nguyen | |||
| Katherine Fitzgerald | |||
| Cynthia Cordeiro | |||
| Renée McKell | |||
| P2860 | cites work | Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development | Q21131617 |
| Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. | Q22255523 | ||
| Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. | Q24520491 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome | Q24611264 | ||
| Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence | Q24617053 | ||
| Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks | Q24633890 | ||
| The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18 | Q27341809 | ||
| Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii | Q28476607 | ||
| Admixture and recombination among Toxoplasma gondii lineages explain global genome diversity | Q28728385 | ||
| Large-scale analysis of the human and mouse transcriptomes | Q29547360 | ||
| DiRE: identifying distant regulatory elements of co-expressed genes | Q33335674 | ||
| Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe | Q33359609 | ||
| Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice | Q33415462 | ||
| A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. | Q33591077 | ||
| Coordinated progression through two subtranscriptomes underlies the tachyzoite cycle of Toxoplasma gondii | Q33701574 | ||
| Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis | Q34012277 | ||
| Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells | Q34033603 | ||
| Strain-dependent host transcriptional responses to Toxoplasma infection are largely conserved in mammalian and avian hosts | Q34056304 | ||
| Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention | Q34102118 | ||
| Interferon-inducible effector mechanisms in cell-autonomous immunity | Q34114819 | ||
| Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. | Q34121309 | ||
| Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses | Q34238191 | ||
| The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. | Q34325516 | ||
| A module map showing conditional activity of expression modules in cancer | Q34353143 | ||
| Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient | Q34474557 | ||
| Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. | Q34501481 | ||
| Toxoplasma gondii clonal strains all inhibit STAT1 transcriptional activity but polymorphic effectors differentially modulate IFNγ induced gene expression and STAT1 phosphorylation | Q34512387 | ||
| NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. | Q34529550 | ||
| A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii | Q34591236 | ||
| Beta interferon suppresses the development of experimental cerebral malaria | Q34740075 | ||
| Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America | Q34843110 | ||
| Type I interferons increase host susceptibility to Trypanosoma cruzi infection | Q34931909 | ||
| Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases | Q35034984 | ||
| Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence | Q35035005 | ||
| Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. | Q35090382 | ||
| Toxoplasma gondii effectors are master regulators of the inflammatory response | Q35434828 | ||
| A monomorphic haplotype of chromosome Ia is associated with widespread success in clonal and nonclonal populations of Toxoplasma gondii | Q35547974 | ||
| Genetic analysis of the diversity in Toxoplasma gondii. | Q35843106 | ||
| Population structure and mouse-virulence of Toxoplasma gondii in Brazil | Q81506276 | ||
| TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii | Q83918213 | ||
| Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages | Q35889275 | ||
| Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009) | Q35948790 | ||
| Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome | Q35973133 | ||
| Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil | Q36026193 | ||
| Parasitic central nervous system infections in immunocompromised hosts | Q36095864 | ||
| Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host | Q36228600 | ||
| The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis | Q36229527 | ||
| Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii | Q36396820 | ||
| Forensic genetics and ethical, legal and social implications beyond the clinic | Q36503211 | ||
| Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection | Q36611354 | ||
| Persistent LCMV infection is controlled by blockade of type I interferon signaling | Q36808119 | ||
| Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses | Q36842908 | ||
| Role of beta interferon in resistance to Toxoplasma gondii infection | Q36968666 | ||
| In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon | Q37030505 | ||
| Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue | Q37087502 | ||
| Polymorphic secreted kinases are key virulence factors in toxoplasmosis | Q37105671 | ||
| Infection with Toxoplasma gondii results in dysregulation of the host cell cycle | Q37109789 | ||
| Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana | Q37164712 | ||
| Stress-related and spontaneous stage differentiation of Toxoplasma gondii. | Q37218715 | ||
| Innate immunity to virus infection. | Q37361448 | ||
| Regulation of effector and memory T-cell functions by type I interferon | Q37841676 | ||
| Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. | Q38969692 | ||
| Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. | Q39163693 | ||
| Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation | Q40051388 | ||
| Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. | Q40164692 | ||
| Host cell invasion by Toxoplasma gondii | Q41712109 | ||
| Blockade of chronic type I interferon signaling to control persistent LCMV infection | Q41807293 | ||
| Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana. | Q42777271 | ||
| TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii | Q44117743 | ||
| IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis | Q44823542 | ||
| Protection against progressive leishmaniasis by IFN-beta. | Q44928980 | ||
| Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice | Q45027585 | ||
| Virulent strains of Toxoplasma gondii comprise a single clonal lineage | Q46105888 | ||
| Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway | Q47810239 | ||
| Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection | Q47982586 | ||
| Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens | Q50023108 | ||
| Unusual abundance of atypical strains associated with human ocular toxoplasmosis. | Q52933346 | ||
| Unresolved questions about the most successful known parasite. | Q53158502 | ||
| Characterization of the factor in L-cell conditioned medium capable of stimulating colony formation by mouse marrow cells in culture | Q56246854 | ||
| Editorial Commentary: High Burden of Congenital Toxoplasmosis in the United States: The Strain Hypothesis? | Q58838824 | ||
| TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi | Q58845148 | ||
| Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection | Q58845209 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P304 | page(s) | e1003779 | |
| P577 | publication date | 2013-12-19 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Transcriptional analysis of murine macrophages infected with different Toxoplasma strains identifies novel regulation of host signaling pathways | |
| P478 | volume | 9 |
| Q58587557 | Acute Infection in Cats Induced Tissue-Specific Transcriptional Response Dominated by Immune Signatures |
| Q57462284 | Characterization of a effector uncovers an alternative GSK3/β-catenin-regulatory pathway of inflammation |
| Q61805859 | Comparison of splenocyte microRNA expression profiles of pigs during acute and chronic toxoplasmosis |
| Q55511992 | Cysteine-Reactive Free ISG15 Generates IL-1β-Producing CD8α+ Dendritic Cells at the Site of Infection. |
| Q36471483 | Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoite and bradyzoite development in vitro and in vivo |
| Q36896842 | Dual Identification and Analysis of Differentially Expressed Transcripts of Porcine PK-15 Cells and Toxoplasma gondii during in vitro Infection |
| Q61806387 | Dual RNA-seq identifies human mucosal immunity protein Mucin-13 as a hallmark of Plasmodium exoerythrocytic infection |
| Q100694095 | Genome-wide screens identify Toxoplasma gondii determinants of parasite fitness in IFNγ-activated murine macrophages |
| Q64074199 | Hypervirulence in the Rat Model Parallels Human Infection and Is Modulated by the Locus |
| Q92755189 | Identification of a Master Regulator of Differentiation in Toxoplasma |
| Q28545027 | Induction of interferon-stimulated genes by IRF3 promotes replication of Toxoplasma gondii |
| Q90630662 | In Vivo CRISPR Screen Identifies TgWIP as a Toxoplasma Modulator of Dendritic Cell Migration |
| Q38994540 | Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways That Can Be Therapeutically Targeted after Spinal Cord Injury. |
| Q53811462 | Mechanisms of interferon-beta-induced inhibition of Toxoplasma gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1. |
| Q52660158 | Microarray analysis of long non-coding RNA expression profiles uncovers a Toxoplasma-induced negative regulation of host immune signaling. |
| Q38673930 | Phosphoproteome of Toxoplasma gondii Infected Host Cells Reveals Specific Cellular Processes Predominating in Different Phases of Infection |
| Q47624929 | Post-translational modifications as key regulators of apicomplexan biology: insights from proteome-wide studies. |
| Q22255525 | Proteome-wide lysine acetylation in cortical astrocytes and alterations that occur during infection with brain parasite Toxoplasma gondii |
| Q35966045 | Proteomic Profiling of Mouse Liver following Acute Toxoplasma gondii Infection |
| Q47215452 | R Script Approach to Infer Toxoplasma Infection Mechanisms From Microarrays and Domain-Domain Protein Interactions |
| Q42612923 | Reply to Wallon and Peyron |
| Q36174010 | STAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling Pathways |
| Q92074119 | Serotyping of Toxoplasma gondii Infection Using Peptide Membrane Arrays |
| Q64118767 | Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat |
| Q33899190 | TRIM21 is critical for survival of Toxoplasma gondii infection and localises to GBP-positive parasite vacuoles. |
| Q92645945 | The GRA15 protein from Toxoplasma gondii enhances host defense responses by activating the interferon stimulator STING |
| Q35619266 | The Toxoplasma Dense Granule Proteins GRA17 and GRA23 Mediate the Movement of Small Molecules between the Host and the Parasitophorous Vacuole. |
| Q38731005 | Toxoplasma Effectors Targeting Host Signaling and Transcription |
| Q91936105 | Toxoplasma GRA15 Activates the NF-κB Pathway through Interactions with TNF Receptor-Associated Factors |
| Q40047888 | Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. |
| Q92623881 | Toxoplasma gondii effector TgIST blocks type I interferon signaling to promote infection |
| Q35066835 | Toxoplasma gondii prevalent in China induce weaker apoptosis of neural stem cells C17.2 via endoplasmic reticulum stress (ERS) signaling pathways |
| Q35172341 | Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination. |
| Q35824601 | Transcriptional and Linkage Analyses Identify Loci that Mediate the Differential Macrophage Response to Inflammatory Stimuli and Infection |
| Q40934842 | Transcriptomic analysis of global changes in cytokine expression in mouse spleens following acute Toxoplasma gondii infection |
| Q38823049 | Unmethylated CpG motifs in Toxoplasma gondii DNA induce TLR9- and IFN-β-dependent expression of α-defensin-5 in intestinal epithelial cells |
| Q59548522 | Unveiling the pathogen behind the vacuole |
Search more.